Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT05997693 |
| Consolidated Lead Sponsor | Weill Medical College of Cornell University |
| Therapeutic Condition Cohort | Cardiovascular and Thrombosis |
| Clinical Trial Phase | Phase III |
| Overall Recruitment Status | RECRUITING |
| Registered Enrollment | 700 participants (ESTIMATED) |
| Registered Start Date | 2024-08-15 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Weill Cornell Medicine | New York, NY | Open Hospital Dossier -> |
| Medical University of Vienna | Vienna, Austria | Open Hospital Dossier -> |
| Ruijin Hospital, Shanghai Jiao Tong University School of Medicine | Shanghai, China | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Cardiovascular and Thrombosis Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.